Bladder cancer and C-reactive protein increased
Summary:
C-reactive protein increased is found among people with Bladder cancer, especially for people who are male, 60+ old.
The study analyzes which people have C-reactive protein increased with Bladder cancer. It is created by eHealthMe based on reports of 30 people who have Bladder cancer from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.
What is Bladder cancer?
Bladder cancer is found to be associated with 725 drugs and 1,028 conditions by eHealthMe. Check the latest studies of Bladder cancer.
What is C-reactive protein increased?
C-reactive protein increased is found to be associated with 1,568 drugs and 2,281 conditions by eHealthMe. Check the latest studies of C-reactive protein increased.
30 people who have Bladder Cancer and C-Reactive Protein Increased are studied.

Gender of people who have Bladder Cancer and experienced C-Reactive Protein Increased *:
- female: 20.69 %
- male: 79.31 %
Age of people who have Bladder Cancer and experienced C-Reactive Protein Increased *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 3.7 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 18.52 %
- 60+: 77.78 %
Common co-existing conditions for these people *:
- Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 4 people, 13.33%
- Polyarthritis (arthritis which involves 5 or more joints simultaneously): 4 people, 13.33%
- Malignant Neoplasm Progression (cancer tumour came back): 1 person, 3.33%
- Lung Cancer - Non-Small Cell (lung cancer): 1 person, 3.33%
Common drugs taken by these people *:
- Methotrexate: 6 people, 20.00%
- Humira: 4 people, 13.33%
- Amlodipine Besylate: 4 people, 13.33%
- Paclitaxel: 4 people, 13.33%
- Padcev: 3 people, 10.00%
- Cisplatin: 3 people, 10.00%
- Novorapid: 2 people, 6.67%
- Gemcitabine Hydrochloride: 2 people, 6.67%
- Taxotere: 2 people, 6.67%
- Levemir: 2 people, 6.67%
Common symptoms for these people *:
- Fever: 12 people, 40.00%
- Malignant Neoplasm Progression (cancer tumour came back): 7 people, 23.33%
- Anaemia (lack of blood): 6 people, 20.00%
- Thrombocytopenia (decrease of platelets in blood): 6 people, 20.00%
- Haemoglobin Decreased: 6 people, 20.00%
- Pneumonia: 4 people, 13.33%
- Arthropathy: 4 people, 13.33%
- Nausea And Vomiting: 4 people, 13.33%
- Red Blood Cell Sedimentation Rate Increased: 4 people, 13.33%
- Chills (felling of cold): 4 people, 13.33%
* Approximation only. Some reports may have incomplete information.
Do you take medications and have C-reactive protein increased?
- Check whether C-reactive protein increased is associated with a drug or a conditionRelated studies:
Treatments, associated drugs and conditions:
- Bladder cancer (75,593 reports)
- C-reactive protein increased (52,373 reports)
All the drugs that are associated with C-reactive protein increased:
- C-reactive protein increased (1,568 drugs)
All the conditions that are associated with C-reactive protein increased:
- C-reactive protein increased (2,281 conditions)
How the study uses the data?
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
The study is based on C-reactive protein increased and Bladder cancer, and their synonyms.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Ibuprofen and Ocaliva - now
- Valium and Topamax drug interactions for girls aged 2-9 - 3 seconds ago
- Could Methocarbamol cause Heart Rate Increased? - 8 seconds ago
- Bisoprolol Fumarate vs. Indapamide, side effect and effectiveness comparison - 9 seconds ago
- Could Nifedipine cause Hot Flush? - 11 seconds ago
- Endep vs. Vitamin B1, side effect and effectiveness comparison - 11 seconds ago
- Metastasis and drugs of ingredients of loratadine - 17 seconds ago
- Drug interactions of Acetaminophen And Hydrocodone Bitartrate and Lipitor - 18 seconds ago
- Trileptal and Itchiness for Women aged 50-59 - 19 seconds ago
- Trileptal and Pruritus for Women aged 50-59 - 19 seconds ago